Breast Cancer Prevention:
Many breast cancer survivors take anti-estrogens for at least five years to help reduce their risk of Breast Cancer recurrence.
Case by case
However, new research the breast suggests that taking such a drug for an even longer period can not confer additional benefits, at least in terms of survival.
The study of thousands of older breast cancer survivors revealed that taking the aromatase inhibitor, letrozole (Femara) for more than five years recommended did the breast not help Breast Cancer them to live longer.
However, other benefits have been noted, so the decision to expand the use of drugs like this is one of the best done on a case-by-case basis, the cancer specialists said.
An oncologist who reviewed new findings said the study was Breast Cancer "eagerly awaited", as many breast cancer survivors are advised to take an aromatase inhibitor.
